Search Results - "Dagis, A."

Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation by Pullarkat, V, Blanchard, S, Tegtmeier, B, Dagis, A, Patane, K, Ito, J, Forman, S J

“…Iron overload is common in patients undergoing allogeneic hematopoietic cell transplantation (HCT) for hematologic disorders. Serum ferritin, a marker of…”
Get full text

Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome by Aldoss, I, Dagis, A, Palmer, J, Forman, S, Pullarkat, V

Get full text

Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia by Stein, A S, O'Donnell, M R, Synold, T W, Dagis, A C, Tsirunyan, A, Nademanee, A P, Parker, P M, Pullarkat, V A, Snyder, D S, Spielberger, R T, Wong, J Y C, Alvarnas, J C, Thomas, S H, Forman, S J

“…Patients with poor-risk leukemia have a high relapse rate despite allogeneic transplant. We report on the phase-2 trial of an intensified allogeneic transplant…”
Get full text

Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation by Pullarkat, V., Slovak, M.L., Dagis, A., Bedell, V., Somlo, G., Nakamura, R., Stein, A.S., O'Donnell, M.R., Nademanee, A., Teotico, A.L., Bhatia, S., Forman, S.J.

“…Although secondary acute leukemias and myelodysplasia are the known complications of adjuvant chemotherapy for breast cancer, the treatment outcome of these…”
Get full text

Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML by SUN, J. Y, GAIDULIS, L, DAGIS, A, PALMER, J, RODRIGUEZ, R, MILLER, M. M, FORMAN, S. J, SENITZER, D

“…Killer Ig-like receptor (KIR) is a major cluster of the natural killer cell receptors and may play a role in the outcome of hematopoietic cell transplants. A…”
Get full text

15-OR: The role of killer-cell Ig-like receptor (KIR) in hematopoietic cell transplantation (HCT) determined by overall alloimmune response by Sun, J.Y, Oki, A, Dagis, A, Gaidulis, L, Forman, S.J, Senitzer, D

Get full text

The Outcome of Matched Unrelated Donor Bone Marrow Transplantation in Patients With Hematologic Malignancies Using Molecular Typing for Donor Selection and Graft-Versus-Host Disease Prophylaxis Regimen of Cyclosporine, Methotrexate, and Prednisone by Nademanee, Auayporn, Schmidt, Gerhard M., Parker, Pablo, Dagis, Andrew C., Stein, Anthony, Snyder, David S., O'Donnell, Margaret, Smith, Eileen P., Stepan, Daniel E., Molina, Arturo, Wong, K.K., Margolin, Kim, Somlo, George, Littrell, Barbara, Woo, Doni, Sniecinski, Irena, Niland, Joyce C., Forman, Stephen J.

“…Graft-versus-host disease (GVHD) is a major obstacle to successful bone marrow transplantation (BMT) from matched unrelated donor (MUD). Currently available…”
Get full text

Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients by CHANG, K. L, O'DONNELL, M. R, SLOVAK, M. L, DAGIS, A. C, ARBER, D. A, NILAND, J. C, FORMAN, S. J

“…Although myelodysplastic syndromes (MDSs) are generally thought to be diseases of elderly patients, younger patients also have rarely been diagnosed with MDS…”
Get full text

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission by SNYDER, D. S, NADEMANEE, A. P, FUNG, H, SLOVAK, M. L, DAGIS, A, NEGRIN, R. S, AMYLON, M. D, BLUME, K. G, FORMAN, S. J, O'DONNELL, M. R, PARKER, P. M, STEIN, A. S, MARGOLIN, K, SOMLO, G, MOLINA, A, SPIELBERGER, R, KASHYAP, A

“…Between 1984 and 1997, 23 consecutive patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in first complete remission were treated with…”
Get full text

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells by Nademanee, A, Sniecinski, I, Schmidt, G M, Dagis, A C, O'Donnell, M R, Snyder, D S, Parker, P M, Stein, A S, Smith, E P, Molina, A

“…To evaluate (1) the effect of granulocyte colony-stimulating factor (G-CSF) on peripheral-blood stem-cell (PBSC) mobilization; (2) the rate of hematopoietic…”
Get more information

PO-1171 Ten-year follow-up of tandem autologous transplantation with total marrow irradiation for myeloma by Ladbury, C., Rincon, A., Song, J., Armenian, S., Liu, A., Spielberger, R., Popplewell, L., Sahebi, F., Parker, P., Forman, S., Snyder, D., Dagis, A., Frankel, P., Yang, D., Wong, J., Somlo, G.

Get full text

Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of life by Schmidt, G M, Niland, J C, Forman, S J, Fonbuena, P P, Dagis, A C, Grant, M M, Ferrell, B R, Barr, T A, Stallbaum, B A, Chao, N J

“…A group of 235 allogeneic marrow recipients were contacted at least one year following their BMT to obtain information on their quality of life; 212 (90%)…”
Get more information

Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease by Chao, Nelson J, Schmidt, Gerhard M, Niland, Joyce C, Amylon, Michael D, Dagis, Andrew C, Long, Gwynn D, Nademanee, Auayporn P, Negrin, Robert S, O'Donnell, Margaret R, Parker, Pablo M, Smith, Eileen P, Snyder, David S, Stein, Anthony S, Wong, Ruby M, Blume, Karl G, Forman, Stephen J

“…Acute graft-versus-host disease (GVHD) is a serious problem in recipients of allogeneic bone marrow grafts 1 . Several approaches have been used to prevent it…”
Get full text

High-Dose Chemotherapy With or Without Total Body Irradiation Followed by Autologous Bone Marrow and/or Peripheral Blood Stem Cell Transplantation for Patients With Relapsed and Refractory Hodgkin's Disease: Results in 85 Patients With Analysis of Prognostic Factors by Nademanee, Auayporn, O'Donnell, Margaret R., Snyder, David S., Schmidt, Gerhard M., Parker, Pablo M., Stein, Anthony S., Smith, Eileen P., Molina, Arturo, Stepan, Daniel E., Somlo, George, Margolin, Kim A., Sniecinski, Irena, Dagis, Andrew C., Niland, Joyce, Pezner, Richard, Forman, Stephen J.

“…Eighty-five consecutive patients with relapsed or refractory Hodgkin's disease (HD) underwent high-dose chemotherapy or chemo/radiotherapy followed by…”
Get full text

High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non m3 acute myelogenous leukemia : impact of cytogenetics on achieving a complete remission by STEIN, A. S, O'DONNELL, M. R, MARGOLIN, K. A, ARBER, D, NILAND, J, FORMAN, S. J, SLOVAK, M, NADEMANEE, A, DAGIS, A, SCHMIDT, G. M, PARKER, P. M, SNYDER, D. S, SMITH, E. P, SOMLO, G

“…Cytogenetic abnormalities are used to define prognostic subgroups of acute myelogenous leukemia (AML) with respect to achieving complete remission (CR) and…”
Get full text

Lung, Renal, Thyroid and Cataract Toxicities after Myeloablative Total Marrow Irradiation (TMI) in Patients Undergoing Hematopoietic Cell Transplantation (HCT) by Wong, J.Y.C., Liu, A., Frankel, P., Schultheiss, T.E., Del Vecchio, B., Dagis, A., Radany, E.H., Hui, S.K., Somlo, G., Stein, A., Rosenthal, J., Forman, S.

Get full text

BK Virus Associated Hemorrhagic Cystitis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant by Shakhnovits, M, DiMundo, J, Pawlowska, A, Wolfson, J, Qian, D, Sorrell, A, Hitt, D, Dagis, A, Cheng, J, Rosenthal, J

Get full text

The Effect of Inhibitory Killer-Cell Ig-Like Receptor(iKIR) Matching in Allogeneic Hematopoietic Cell Transplantation(HCT) by Senitzer, D, Sun, J.Y, Gaidulis, L, Oki, A, Dagis, A, Palmer, J, Forman, S.J

Get full text

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma by Nademanee, Auayporn, Forman, Stephen, Molina, Arturo, Fung, Henry, Smith, David, Dagis, Andy, Kwok, Cheuk, Yamauchi, Dave, Anderson, Anne-Line, Falk, Peter, Krishnan, Amrita, Kirschbaum, Mark, Kogut, Neil, Nakamura, Ryotaro, O'Donnell, Margaret, Parker, Pablo, Popplewell, Leslie, Pullarkat, Vinod, Rodriguez, Roberto, Sahebi, Firoozeh, Smith, Eileen, Snyder, David, Stein, Anthony, Spielberger, Ricardo, Zain, Jasmine, White, Christine, Raubitschek, Andrew

“…We conducted a phase 1/2 trial of high-dose 90Y-ibritumomab tiuxetan in combination with high-dose etoposide (VP-16) 40 to 60 mg/kg (day -4) and…”
Get full text

Is Low Dose Cyclophosphamide Plus G-CSF Moblization As Effective As Mozobil (Plerixafor) Plus G-CSF In Multiple Myeloma (MM) Patients Eligible For Tandem Transplant? by Karanes, C, Dagis, A, Wang, S, Krishnan, A, Sahebi, F, Popplewell, L, Parker, P, Forman, S, Palmer, J, Kogut, N, Somlo, G

Get full text